Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

Request the impact of COVID-19 in this market at no additional cost. Buy it today to get an advantage.

Request Now


Technology advancements, portability, and fusion technology applications are expected to drive the global medical equipment industry. The industry experienced average growth over the last five years and is expected to reach approximately US $93.6 billion in 2017 with a CAGR of 4.1% over the next five years.

Lucint

el, a leading global management consulting and market research firm, has conducted a competitive analysis of the global medical equipment companies and presents its findings in “Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis.” The report provides detailed insight into the performance of the top five companies across the world. The analysis highlights the companies that are performing the best among the peer group, and in which areas, and therefore clarifies leading performance standards and the strengths and weaknesses of companies covered.

The global medical equipment market consists of the total revenues generated through ophthalmic equipment such as retinal cameras and ophthalmoscopes; in vitro diagnostic such as clinical diagnostic and immunoassay; diagnostic imaging equipment including X-ray, MRI, CT scan, and ultrasound; and dental equipment. In this study, Lucintel profiles the following five companies with detailed competitive assessments:
 
  • Abbott                
  • General Electric        
  • Philips                                                    
  • Roche        
  • Siemens              
                                              
As per the study, dental equipment was the fastest-growing segment during 2006-2011 as introduction of CAD/CAM systems and laser technology resulted in cost effectiveness and better performance. The proportion of people over 65 years of age is increasing globally, enhancing the propensity of tooth replacement. Asia Pacific is currently a developing region and with improvement in economy, there is good growth potential in future. Governments in many Asian countries are ramping up efforts to increase medical insurance coverage and establish more hospitals

This study is intended to provide industry leaders with a competitive benchmarking of the world’s top five medical equipment companies. The study provides up-to-date information on the market share, profit margins, capabilities, and strategies of the leaders. It is designed to provide executives with strategically significant competitor information, data analysis, and insight, critical to the development and implementation of an effective marketing and sales plan.

Medical equipment companies competitive analysis report will save hundreds of hours of your own personal research time and will significantly benefit you in expanding your business opportunities in global medical equipment companies industry. In today’s chaotic economy, you need every advantage that you can find to keep ahead in your business

In Lucintel's newest competitive research study on the world's medical equipment companies, we thoroughly profile following five companies with detailed competitive assessments:
 
  • Abbott                
  • General Electric        
  • Philips                                                    
  • Roche
  • Siemens

The detailed analysis of each company offers a critical view into key strategic areas, including:
  • Company overview          
  • Benchmarking (financial & market)
  • SWOT analysis         
  • Product positioning
  • Marketing strategy and tactics    
  • Corporate strategy
To make any investment, business or strategic decisions, you need adequate and timely information. Medical equipment companies competitive analysis market report fulfills this core need. This is an indispensable reference guide for industry executives who are dealing with medical equipment companies industry.

Some of the features of Top Five Global Medical Equipment Companies: Performance, Strategies, and Competitive Analysis market intelligence report are:
  • Market size estimates in terms of (US $) value by segments of the global medical equipment companies
  • Regional analysis: global medical equipment companies breakdown by key regions (e.g., North America, Europe, APAC and ROW)
  • Medical equipment market trends, drivers and forecasts
  • Competitive benchmarking of each players against their financial & market strength
  • Global and regional market share estimates for the top players
  • Product line overview and positioning of top players
  • SWOT analysis of the leaders
  • Marketing strategy and tactics    
  • Corporate strategy
  • More than 108 valuable figures/charts and 45 tables are provided in this report
     
 1. Executive Summary  

 2. Market Definition and Scope  

 3. Market Opportunity  

 4. Competitive Benchmarking (Financial and Market)  

 5. Company Profile on Following Parameters  

 6. Profiles on Following Companies  
 6.1. Abbott  
 6.2. General Electric Company  
 6.3. Philips  
 6.4. Roche  
 6.5. Siemens  

List of Figures
 
CHAPTER 3. Market Opportunity
Figure 3.1: Supply chain for medical equipment market
Figure 3.2: Global medical equipment industry annual trend 2006-2011 (US $B)
Figure 3.3: Global medical equipment industry regional trend 2006-2011 (US $B)
Figure 3.4: Global medical equipment industry regional trend 2006-2011 (%)
Figure 3.5: Global medical equipment industry segment trend 2006-2011 (US $B)
Figure 3.6: Global medical equipment industry segment trend 2006-2011 (%)
Figure 3.7: Global medical equipment industry opportunity by region
Figure 3.8: Global medical equipment industry opportunity by segment
    
CHAPTER 4.Competitive Benchmarking (Financial and Market)
Figure 4.1: Top five medical equipment companies – financial benchmarking
Figure 4.2: Global top five medical equipment companies gross profit and net profit analysis – 2011
Figure 4.3: Financial analysis – growth leadership quadrant (2011)
Figure 4.4: Market share of top players 2006
Figure 4.5: Market share of top players 2011
Figure 4.6: 2006 Market share analysis
Figure 4.7: 2011 Market share analysis
Figure 4.8: Global market share analysis 2011
Figure 4.9: Global market fragmentation 2011  
Figure 4.10: Market value North America: (US $B)
Figure 4.11: Market value Europe (US $B)
Figure 4.12: Market value Asia Pacific (US $B)
Figure 4.13: Market value Row (US $B)
Figure 4.14: Regional revenue evaluation 2011(US $M)
Figure 4.15: Regional revenue evaluation 2011(%)
Figure 4.16: North American revenue trend for top players 2007-2011 (US $B)
Figure 4.17: Europe revenue trend for top players 2007-2011 (US $B)
Figure 4.18: Asia Pacific revenue trend for top players 2007-2011 (US $B)
Figure 4.19: Row revenue trend for top players 2007-2011 (US $B)
Figure 4.20: Lucintel triad - top five major players
 
CHAPTER 5. Company Profile of Abbott
Figure 5.1: Abbott’s revenue by business structure 2011
Figure 5.2: Lucintel Triad – Abbott
Figure 5.3: Financial benchmarking Abbott against top three and top five industry players’ average
Figure 5.4: Financial benchmarking of Abbott against Top Five best
Figure 5.5: Global industry revenue trend Vs Abbott (2007-2011) in US $B
Figure 5.6: Global market share trend for Abbott (2007-2011) in (%)
Figure 5.7: North American industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.8: European industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.9:   APAC industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.10: ROW industry revenue trend Vs. Abbott 2007-2011 in (US $B)
Figure 5.11: North American market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.12: European market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.13: APAC market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.14: ROW market share trend Vs. Abbott 2007-2011 in (%)
Figure 5.15: Abbott trend in R&D expenses 2007-2011 in US $M
Figure 5.16: Abbott trend in R&D expenses Percentage of total revenue
Figure 5.17: Comparison of Abbott SE R&D expenditure vs. top three & top five players average 2011
Figure 5.18: Abbott productivity 2007-2011 (US $M)
Figure 5.19: Abbott capital investment value 2007-2011 (US $M)
Figure 5.20: Strategic execution
 
CHAPTER 6. Company Profile of General Electric
Figure 6.1: General Electric revenue by business structure 2011
Figure 6.2: Lucintel triad - General Electric
Figure 6.3: Financial benchmarking of General Electric against top three and top five industry players’ average
Figure 6.4: Financial benchmarking of General Electric against Top five best
Figure 6.5: Global industry revenue trend Vs. General Electric (2007-2011) in (US $B)
Figure 6.6: Global market share trend for General Electric (2007-2011) in (%)
Figure 6.7: North American industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.8: European industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.9: APAC industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.10: ROW industry revenue trend Vs. General Electric 2007-2011 in (US $B)
Figure 6.11: North American market share trend Vs. General Electric 2007-2011 in (%)
Figure 6.12: European market share trend Vs. General Electric 2007-2011 in (%)
Figure 6.13: APAC market share trend Vs. DuPont 2007-2011 in (%)
Figure 6.14: ROW market share trend Vs. DuPont 2007-2011 in (%)
Figure 6.15: General Electric trend in R&D expenses 2007-2011 in US
Figure 6.16: General Electric trend in R&D expenses Percentage of total revenue
Figure 6.17: Comparison of General Electric SE R&D expenditure vs. top three & top five players average 2011
Figure 6.18: General Electric productivity: 2007-2011 in (US $M)
Figure 6.19: General Electric capital investment value: 2007-2011 in (US $M)
Figure 6.20: Strategic execution
 
CHAPTER 7. Company Profile of Philips
Figure 7.1: Philips revenue by business structure 2011
Figure 7.2: Lucintel triad – Philips
Figure 7.3: Financial benchmarking of Philips against top three and top five industry players’ average
Figure 7.4: Financial benchmarking of Philips against Top five best
Figure 7.5: Global industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.6: Global market share trend for Philips (2007-2011) in (%)
Figure 7.7: North American industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.8: European industry revenue trend Vs. Philips l (2007-2011) in(US $B)
Figure 7.9: APAC industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.10: ROW industry revenue trend Vs. Philips (2007-2011) in (US $B)
Figure 7.11: North American market share trend Vs. Philips (2007-2011) in (%)
Figure 7.12: European market share trend Vs. Philips l (2007-2011) in (%)
Figure 7.13: APAC market share trend Vs. Philips (2007-2011) in (%)
Figure 7.14: ROW market share trend Vs. Philips (2007-2011) in (%)
Figure 7.15: Philips trend in R&D expenses 2007-2011 in US $M
Figure 7.16: Philips trend in R&D expenses Percentage of total revenue
Figure 7.17: Comparison of Philips R&D expenditure vs. top three & top five players average 2011
Figure 7.18: Philips productivity 2007-2011 in (US $M)
Figure 7.19: Philips capital investment value 2007-2011 in (US $M)
Figure 7.20: Strategic execution
 
CHAPTER 8. Company Profile of Roche
Figure 8.1: Roche revenue by business structure 2011
Figure 8.2: Lucintel triad – Roche
Figure 8.3: Financial benchmarking of Roche against top three and top five industry players’ average
Figure 8.4: Financial benchmarking of Roche against Top five best
Figure 8.5: Global industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.6: Global market share trend for Roche (2007-2011) in (%)
Figure 8.7: North American industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.8: European industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.9: APAC industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.10: ROW industry revenue trend Vs. Roche (2007-2011) in (US $B)
Figure 8.11: North American market share trend Vs. Roche (2007-2011) in (%)
Figure 8.12: European market share trend Vs. Roche (2007-2011) in (%)
Figure 8.13: APAC market share trend Vs. Roche (2007-2011) in (%
Figure 8.14: ROW market share trend Vs. Roche (2007-2011) in (%)
Figure 8.15: Roche trend in R&D expenses 2007-2011 in US $M
Figure 8.16: Roche trend in R&D expenses Percentage of total revenue
Figure 8.17: Comparison of Roche R&D expenditure vs. top three & top five players average 2011
Figure 8.18: Roche productivity: 2007-2011 in (US $M)
Figure 8.19: Roche capital investment value: 2007-2011 in (US $M)
Figure 8.20: Strategic execution
 
CHAPTER 9. Company Profile of Siemens
             Figure 9.1: Siemens revenue by business structure 2011
Figure 9.2: Lucintel triad – Siemens
Figure 9.3: Financial benchmarking of Siemens against top three and top five industry players’ average
Figure 9.4: Financial benchmarking of Siemens against Top five best
Figure 9.5: Global industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.6: Global market share trend for Siemens (2007-2011) in (%)
Figure 9.7: North American industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.8: European industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.9: APAC industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.10: ROW industry revenue trend Vs. Siemens (2007-2011) in (US $B)
Figure 9.11: North American market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.12: European market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.13: APAC market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.14: ROW market share trend Vs. Siemens (2007-2011) in (%)
Figure 9.15: Siemens trend in R&D expenses 2007-2011 in US $M
Figure 9.16: Siemens trend in R&D expenses Percentage of total revenue
Figure 9.17: Comparison of IMERYS R&D expenditure Vs. top three & top five players average 2011
Figure 9.18: Siemens productivity 2007-2011 in (US $M)
Figure 9.19: Siemens capital investment value 2007-2011 in (US $M)
Figure 9.20: Strategic execution
 
 
List of Tables
 
CHAPTER 3. Market Opportunity
Table 3.1: Industry parameters of global pulp and paper chemical industry
Table 3.2: Relative market attractiveness by region
Table 3.3: Regional revenue growth rate
Table 3.4: Segment revenue growth rate
 
CHAPTER 4. Competitive Benchmarking (Financial and Market)
Table 4.1: Financial benchmarking of top five global pulp and paper chemical companies
Table 4.2: Key financial parameters for top five pulp and paper chemical companies
Table 4.3: Regional revenue (US $B)
Table 4.4: Regional revenue (%)
Table 4.5: Competitors based on markets served
Table 4.6: Lucintel triad - Top five major players
 
CHAPTER 5. Company Profile of Abbott
Table 5.1:  Market served: Abbott
Table 5.2:  Lucintel triad – Abbott
Table 5.3:  Financial Benchmarking of Abbott against best and against Top three and Top five industry players’ average
Table 5.4:  Strategic execution – product positioning by segment
Table 5.5:  Strategic execution – perceived customer value / quality
Table 5.6:  Strategic execution – promotion / communications
Table 5.7:  Strategic execution – product distribution by region
 
CHAPTER 6. Company Profile of General Electric  
Table 6.1: Market served – General Electric  
Table 6.2: Lucintel triad – General Electric  
Table 6.3: Financial benchmarking of General Electric against   best and against Top three and Top five industry players’ average
Table 6.4: Strategic execution – product positioning by segment
Table 6.5: Strategic execution – perceived customer value / quality
Table 6.6: Strategic execution – promotion / communications
Table 6.7: Strategic execution – product distribution by region
 
CHAPTER 7. Company Profile of Philips
Table 7.1: Market served – Philips
Table 7.2: Lucintel triad – Philips
Table 7.3: Financial benchmarking of Philips against best and against Top three and Top five industry players’ average
Table 7.4: Strategic execution – product positioning by segment
Table 7.5: Strategic execution – perceived customer value / quality
Table 7.6: Strategic execution – promotion / communications
Table 7.7: Strategic execution – product distribution by region
 
CHAPTER 8. Company Profile of Roche
Table 8.1: Market served – Roche
Table 8.2: Lucintel triad – Roche
Table 8.3: Financial Benchmarking of Roche against best and against Top three and top five industry players’ average
Table 8.4: Strategic execution – product positioning by segment
Table 8.5: Strategic execution – perceived customer value / quality
Table 8.6: Strategic execution – promotion / communications
Table 8.7: Strategic execution – product distribution by region
 
CHAPTER 9. Company Profile of Siemens
Table 9.1: Markets served – Siemens
Table 9.2: Lucintel triad – Siemens
Table 9.3: Financial Benchmarking of Siemens against best and against Top three and top five industry players’ average
Table 9.4: Strategic execution – product positioning by segment
Table 9.5: Strategic execution – perceived customer value / quality
Table 9.6: Strategic execution – promotion / communications
Table 9.7: Strategic execution – product distribution by region
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Medical Equipment Companies Analysis Full Report $ 1,980
More than 43 valuable figures/charts and 11 tables are provided in this report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Medical Equipment Companies Analysis.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?